EUVIMEDEUVIMED entdecken
Multizentrische Studie

The Association of Hematological Markers with Occurrence of Thrombotic and Bleeding Events following Left Atrial Appendage Occlusion

Errol Aarnink, Domenico Della Rocca, Pedro Cepas-Guillen, Tomás Benito-González, Amin Polzin, Luca Branca, Daniel Spoon, Marianna Adamo, Xavier Freixa, Andrea Natale, Lucas V A Boersma

Cardiology · 22.07.2024 · 150 (6) · 701-708

DOI: 10.1159/000540240 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Cardiology, online erschienen am 22.07.2024. Verfasst von Errol Aarnink und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands, e.aarnink@antoniusziekenhuis.nl. Hauptthemen laut MEDLINE: Left Atrial Appendage Closure, Atrial Fibrillation, Thromboembolism, Thrombosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Patients undergoing left atrial appendage occlusion (LAAO) are at increased risk for bleeding or thromboembolic events. Concurrently, biomarkers are of growing importance in risk stratification for atrial fibrillation patients. We aimed to evaluate the association of hematological markers and clinical characteristics with the occurrence of thromboembolic and bleeding events following LAAO.

Methods

Seven implanting centers retrospectively gathered data on hematological markers (i.e., platelet count [PC], mean platelet volume [MPV], and fibrinogen) prior to LAAO. Prespecified thromboembolic and major bleeding outcomes were collected and the association with pre-procedural hematological markers and clinical characteristics was evaluated using Cox regression analysis.

Results

In total, 1,315 patients were included (74 ± 9 years, 36% female, CHA2DS2-VASc 4.3 ± 1.5, HAS-BLED 3.3 ± 1.1). Over a total follow-up duration of 2,682 patient years, 77 thromboembolic events and 107 major bleeding events occurred after LAAO. Baseline PC was the only biomarker showing a signal for a relation to thromboembolic events (HR 1.18, 95% CI: 1.00–1.39) per 50*109 increment, p = 0.056). Thrombotic event rates, including device-related thrombus, increased within higher PC quartiles. Thromboembolism was associated with age (HR 1.05, 95% CI: 1.00–1.10, per year increase) and prior thromboembolism (HR 2.08, 95% CI: 1.07–4.03), but with none of the biomarkers in multivariate analysis. No association of any of the hematological markers with major bleeding was observed. Major bleeding following LAAO was associated with prior major bleeding (HR 5.27, 95% CI: 2.71–10.22), renal disease (HR 1.93, 95% CI: 1.17–3.18), and discharge on dual antiplatelet therapy (DAPT) (HR 1.71, 95% CI: 1.05–2.77).

Conclusion

Most thrombotic events occurred in the highest PC quartile, but no association of any of the hematological markers with thromboembolism or major bleeding was observed in our analysis. In multivariate analysis, older age and prior thromboembolism were associated with thromboembolism. Prior major bleeding, renal disease and discharge on DAPT were multivariate predictors of major bleeding after LAAO.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Left Atrial Appendage ClosureAtrial FibrillationThromboembolismThrombosisHemorrhageAtrial AppendageHumansFemaleMaleRetrospective StudiesBiomarkersAgedFibrinogenPlatelet CountRisk FactorsAged, 80 and overMean Platelet VolumeProportional Hazards ModelsRisk Assessment

Stichwörter der Autor:innen

Atrial fibrillationBleeding riskIschemic strokeLeft atrial appendage closureRisk stratification

Substanzen

BiomarkersFibrinogen

Autor:innen und Institutionen

  • Department of Cardiology, St. Antonius Hospital, Nieuwegein, The Netherlands, e.aarnink@antoniusziekenhuis.nl.
  • Department of Cardiology, Amsterdam University Medical Center, Amsterdam, The Netherlands, e.aarnink@antoniusziekenhuis.nl.
  • Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
  • Cardiovascular Institute, Hospital Clínic, Barcelona, Spain.
  • Universitat de Barcelona, Barcelona, Spain.
  • Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

Zitieren

APA

Aarnink, E., Della Rocca, D., Cepas-Guillen, P., Benito-González, T., Polzin, A., Branca, L., Spoon, D., Adamo, M., Freixa, X., Natale, A., & Boersma, L. V. A. (2024). The Association of Hematological Markers with Occurrence of Thrombotic and Bleeding Events following Left Atrial Appendage Occlusion. Cardiology, 150(6), 701-708. https://doi.org/10.1159/000540240

Vancouver

Aarnink E, Della Rocca D, Cepas-Guillen P, Benito-González T, Polzin A, Branca L, et al. The Association of Hematological Markers with Occurrence of Thrombotic and Bleeding Events following Left Atrial Appendage Occlusion. Cardiology. 2024;150(6):701-708. doi:10.1159/000540240

BibTeX
@article{Aarnink2024,
  author = {Aarnink, Errol and Della Rocca, Domenico and Cepas-Guillen, Pedro and Benito-González, Tomás and Polzin, Amin and Branca, Luca and Spoon, Daniel and Adamo, Marianna and Freixa, Xavier and Natale, Andrea and Boersma, Lucas V A},
  title = {The Association of Hematological Markers with Occurrence of Thrombotic and Bleeding Events following Left Atrial Appendage Occlusion},
  journal = {Cardiology},
  year = {2024},
  volume = {150},
  number = {6},
  pages = {701--708},
  doi = {10.1159/000540240}
}
Kostenlos starten →